Race/Ethnicity and Nonadherence to Prescription Medications Among Seniors: Results of a National Study
- 20 September 2007
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 22 (11) , 1572-1578
- https://doi.org/10.1007/s11606-007-0385-z
Abstract
Nonadherence to prescription drugs results in poorer control of chronic health conditions. Because of significant racial/ethnic disparities in the control of many chronic diseases, differences in the rates of and reasons for medication nonadherence should be studied. 1) To determine whether rates of and reasons for medication nonadherence vary by race/ethnicity among seniors; and 2) to evaluate whether any association between race/ethnicity and nonadherence is moderated by prescription coverage and income. Cross-sectional national survey, 2003. Medicare beneficiaries ≥65 years of age, who reported their race/ethnicity as white, black, or Hispanic, and who reported taking at least 1 medication (n = 14,829). Self-reported nonadherence (caused by cost, self-assessed need, or experiences/side effects) during the last 12 months. Blacks and Hispanics were more likely than whites to report cost-related nonadherence (35.1%, 36.5%, and 26.7%, respectively, p < .001). There were no racial/ethnic differences in nonadherence caused by experiences or self-assessed need. In analyses controlling for age, gender, number of chronic conditions and medications, education, and presence and type of prescription drug coverage, blacks (odds ratio [OR] 1.38; 95% confidence interval [CI] 1.08–1.78) and Hispanics (1.35; 1.02–1.78) remained more likely to report cost-related nonadherence compared to whites. When income was added to the model, the relationship between cost-related nonadherence and race/ethnicity was no longer statistically significant (p = .12). Racial/ethnic disparities in medication nonadherence exist among seniors, and are related to cost concerns, and not to differences in experiences or self-assessed need. Considering the importance of medication adherence in controlling chronic diseases, affordability of prescriptions should be explicitly addressed to reduce racial/ethnic disparities.Keywords
This publication has 33 references indexed in Scilit:
- Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s SeniorsJournal of General Internal Medicine, 2007
- How The New Medicare Drug Benefit Could Affect Vulnerable PopulationsHealth Affairs, 2006
- Who Failed To Enroll In Medicare Part D, And Why? Early ResultsHealth Affairs, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Prescription Drug Coverage And Seniors: Findings From A 2003 National SurveyHealth Affairs, 2005
- Do Drug Benefits Help Medicare Beneficiaries Afford Prescribed Drugs?Health Affairs, 2004
- Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of CareMedical Care, 2004
- Prescription Drug Coverage And Seniors: How Well Are States Closing The Gap?Health Affairs, 2002
- Self-restriction of medications due to cost in seniors without prescription coverageJournal of General Internal Medicine, 2001
- The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical EvidenceAnnual Review of Public Health, 2001